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Oxidation of NADH in themitochondrial matrix of aerobic cells is catalysed bymitochondrial complex I. The reg-
ulation of this mitochondrial enzyme is not completely understood. An interesting characteristic of complex I
from some organisms is the ability to adopt two distinct states: the so-called catalytically active (A) and the
de-active, dormant state (D). The A-form in situ can undergo de-activation when the activity of the respiratory
chain is limited (i.e. in the absence of oxygen). The mechanisms and driving force behind the A/D transition of
the enzyme are currently unknown, but several subunits are most likely involved in the conformational rear-
rangements: the accessory subunit 39 kDa (NDUFA9) and the mitochondrially encoded subunits, ND3 and
ND1. These three subunits are located in the region of the quinone binding site. The A/D transition could repre-
sent an intrinsic mechanism which provides a fast response of the mitochondrial respiratory chain to oxygen
deprivation. The physiological role of the accumulation of the D-form in anoxia ismost probably to protect mito-
chondria from ROS generation due to the rapid burst of respiration following reoxygenation. The de-activation
rate varies in different tissues and can be modulated by the temperature, the presence of free fatty acids and di-
valent cations, theNAD+/NADH ratio in thematrix, the presence of nitric oxide and oxygen availability. Cysteine-
39 of the ND3 subunit, exposed in the D-form, is susceptible to covalent modiﬁcation by nitrosothiols, ROS and
RNS. TheD-form in situ could reactwith natural effectors inmitochondria orwith pharmacological agents. There-
fore themodulation of the re-activation rate of complex I could be away to ameliorate the ischaemia/reperfusion
damage. This article is part of a Special Issue entitled: 18th European Bioenergetic Conference. Guest Editors:
Manuela Pereira and Miguel Teixeira.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).
1. Introduction
Complex I or NADH:ubiquinone oxidoreductase is a key enzyme of
respiration in eukaryotes. In mitochondria, this enzyme is responsible
for the oxidation of NADH produced through glycolysis, the Krebs
cycle and β-oxidation of fatty acids. Complex I reduces ubiquinone (Q)
and transports protons across the inner membrane, contributing to
the proton-motive force [1,2]. The enzyme is probably a major
contributor to the production of reactive oxygen species in mitochon-
dria [3–5]. The catalytic properties of mitochondrial complex I oxidore-
ductase are not simple (for a review see [6]). In addition, mitochondrial
complex I from mammals and some other species can adopt two cata-
lytically and structurally different states, the so-called active (A) and
de-active, dormant (D) conformation.
The presence of these two forms of complex I results in unusual
kinetic parameters when mitochondrial preparations catalyse the
inhibitor-sensitive NADH:Q oxidoreductase reaction. Depending on
the preparation “history” (i.e. thermal treatment or preincubation
with substrates) the initial NADH oxidation proceeds with a lag-phase
(Fig. 1A) [7]. However, the ﬁnal steady-state rate is linear and depends
on assay conditions and on the amount of added enzyme. Although this
behaviour was originally observed many years ago [7–9], it was
characterised in further detail more than 30 years later and referred to
as the A/D transition (see [6,10] for reviews).
The occurrence of the A/D transition was initially demonstrated for
bovine complex I in preparations of heart submitochondrial particles
(SMP) [11] and enzyme isolated by the Hateﬁ protocol [12]. Recently,
it was also shown by Hirst's group with puriﬁed bovine enzyme
reconstituted in proteoliposomes [13]. The enzyme spontaneously
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converts to the D-form after exposure of the idle preparations of mito-
chondria [14], SMP [11] or puriﬁed complex I [12,13] to elevated, but
physiological temperatures (N30 °C) in the absence of substrate
(when catalytic turnover cannot occur). Such preparations show a
considerable lag-phase during continuous assay of the NADH:ubiqui-
none oxidoreductase reaction (Fig. 1A, DSH). Addition of a small (5–
10 μM) pulse of NADH before the assay results in activation of the en-
zyme during one or several slow turnovers when NADH is oxidised
and ubiquinone is reduced. Pre-treatmentwith NADH completely elim-
inates the lag-phase, the enzyme then becomes fully active and cataly-
ses the oxidation of NADH at a linear rate (Fig. 1A, A) [11,12]. In the
presence of divalent cations (Mg2+, Ca2+) or at alkaline pH, the
turnover-dependent activation takes longer and the lag phase is more
pronounced (Fig. 1A, DSH). Divalent cationshave no effect on the activity
of the A-form.
Most of our knowledge on the kinetics of the A/D transition originat-
ed from membrane or puriﬁed preparations of the enzyme. It is likely
that in highly metabolising tissues like heart, muscle and brain, at oxy-
gen concentrations of 5–30 μM [15–17] most of complex I is in the A-
form (Fig. 1B). However, under conditions in which respiration rate is
decreased, the redox centres of the respiratory chain are in a reduced
state due to the slowing of the cytochrome c oxidase. As a result, the
turnover of complex I becomes restricted because of the lack of the elec-
tron acceptor ubiquinone. Therefore, the enzymewould be readily con-
verted into the D-form (Fig. 1B, A→D transition) depending on the
presence of natural effectors of the transition and overall rate of respira-
tion [18].
The kinetics of the pseudoreversible A/D transition has been de-
scribed in mammalian [11] and other eukaryotic complex I [19] and
reviewed elsewhere [6,10]. However, the structural differences be-
tween the two conformations and the physiological role of this process
were recently studied inmore detail by our group and others. In this re-
view we aim to summarise current knowledge on the A/D transition of
mitochondrial complex I.
2. Differences between the A and the D-forms
2.1. Diagnostic tests
Based on (i) the inhibitory effect of alkaline pH and divalent cations
on the activation rate and (ii) on the sensitivity of the D-form to SH-
reagents, there are currently only twodiagnostic tests for the estimation
of the A- and D-form fractions in preparations of complex I. The content
of both forms can be estimated bymeasuring the NADH oxidase activity
of the untreated preparation in conditions arresting the activation (the
A-fraction only). This should be compared with the same sample in
the same measuring conditions after complex I is fully activated (total
enzyme, A + D fractions together). Preparations of intact mitochondria
require permeabilisation or inner membrane disruption prior to mea-
surement in order that the active site of complex I is available for
NADH [20,21].
(i) A convenient method for the determination of the A/D ratio in
membrane preparations of complex I is based on the fact that
at alkaline pH (N8.5) and in the presence of divalent cations
(1–5 mM Ca2+ or Mg2+) the rate of the D→A transition is de-
creased by several orders of magnitude [22]. In these conditions,
the initial rate of NADH oxidase or NADH:Q oxidoreductase
Fig. 1. Scheme illustrating the functional and structural aspects of the A/D transition of mitochondrial complex I. A. Time-course of the NADH:ubiquinone (Q) oxidoreductase reaction
catalysed by the active (A), deactive (DSH) and irreversiblymodiﬁed (DS⁎) forms of the enzyme curves. The A-form of the enzyme catalyses the fast physiological NADH:Q oxidoreductase
reaction with a linear rate insensitive to cysteine-modifying reagents such as nitrosothiols, peroxynitrite or ROS. NADH:Q oxidoreductase reaction catalysed by the D-form of the enzyme
(DSH) proceedswith a lag phasewhen theD→A conversion takes place. The lag phase is signiﬁcantly prolonged in the presence of divalent cations or at alkaline pH. Covalentmodiﬁcation
of the Cys-39 residue of subunit ND3 of the D-form prevents complex I from undergoing turnover-dependent reactivation and irreversibly inhibits the enzyme (DS⁎). B. Possible sequence
of events in conditions of ischaemia or lack of oxygen. If oxygen is absent the A-form (A) spontaneously converts to the D-form (DSH), which can be re-activated back in the case of reox-
ygenation (given substrate ubiquinone availability). Depending on the particular conditions in situ the ND3 thiol group residue can be reversibly S-nitrosated by nitrosothiols (DSNO) or
irreversibly oxidised by peroxynitrite or ROS (DS⁎). In the latter case the enzyme is irreversibly inhibited making this the initial step of mitochondrial damage in I/R. S-nitrosated enzyme
(DSNO) can be reduced by mitochondrial glutathione and thioredoxin [90,117] therefore further delaying the re-activation of the complex I at the early stages of reperfusion.
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accurately corresponds to the activity attributable only to the A-
form, since the activation time of the D-form is signiﬁcantly
longer than the time of the assay. The total amount of enzyme
(A + D) can be estimated after full activation of complex I by
preincubation of the sample with a small (5–10 μM) pulse of
NADH at neutral pH prior to addition of an excess of the alkaline
(pH 8.5–8.8) measuring medium containing 150 μM NADH and
1–5 mM Ca2+ or Mg2+ [23,24].
(ii) Since the chemical modiﬁcation of the D-form results in irrevers-
ible arrest of enzyme activation, the percentage of the A-form
only can be estimated after treatment of the preparation with
SH-reagents, such as NEM or DTNB. The residual NEM-
insensitive NADH oxidase or NADH:Q oxidoreductase activity
would correspond to only the A-form of complex I. The total en-
zymatic activity (A + D) of the preparation can be measured
after activation of the enzyme with a pulse of NADH followed
by the addition of NEM.
The inhibitory effect of SH-reagents on the D-form of complex I
in bovine heart SMP can be assessed by NADH oxidase or NADH:Q oxi-
doreductase activity which are usually affected to a similar extent
[12,22,25,26]. This indicates a direct effect on complex I and not on
downstream components of the respiratory chain. However, the opti-
mal concentration of NEM (0.1–1 mM) should be determined before
usingmitochondrialmembranes or isolated enzyme from other species,
permeabilisedmammalian cells and proteins extracted fromblue native
gel. Furthermore, the oxidation of NADH by artiﬁcial acceptors, such as
hexaammineruthenium (HAR) [27], ferricyanide [28] or tetrazolium,
routinely used for determination of in-gel activity of complex I [29], is
not affected by the A/D transition [12,25] and therefore does not depend
on the modiﬁcation of the D-form by SH-reagents.
Given necessary optimisation, these two methods can be used for
the estimation of the A/D content in cells, muscle ﬁbres or tissue
slices. After anoxic incubation or conditions of metabolic or chemical
hypoxia [5,30–32], the preparation can be treated with a membrane
permeable SH-reagent, such as NEM followed by plasma membrane
permeabilisation with digitonin or saponin. The channel-forming
antibiotic alamethicin can then be used to permeabilise the inner mi-
tochondrial membrane to exogenously-added NADH [18,21]. The
NEM-treatment could potentially inactivate any of the D-form of
complex I present in mitochondria. Therefore, adding exogenous
NADH and estimating rotenone-sensitive NADH oxidase activity will
give a measure of only the A-form present in the preparation at the
time of NEM-treatment. Provided all the necessary controls such as a
test for completeness of membrane permeabilisation and succinate
oxidase activity measurements are carried out, the time course of de-
activation of complex I in particular conditions can be determined.
The A/D transition should be taken into account when measuring
complex I-dependent activities in crude mitochondrial membrane
preparations isolated from tissues obtained from animal models. It is
likely that any chemical treatment/pharmacological intervention affect-
ing oxygenmetabolism or animal models of oxygen deprivation (global
ischaemia, local infarction or stroke)would result in a signiﬁcant shift in
the A/D equilibrium. Depending on the degree of de-activation of the
enzyme in situ and theparticular conditions ofmitochondrialmembrane
isolation, a signiﬁcant fraction of the enzyme is expected to be in the D-
form in the ﬁnal preparation. It should be stressed that when using a
medium at alkaline pH or/and supplemented with Mg2+ or Ca2+ for
measuring complex I activity [33–37] the turnover-dependent re-
activation (D→A transition) may take a signiﬁcant amount of time.
This could look like an apparent inhibition of the complex I-dependent
reaction if the assay is started with a partially de-activated enzyme.
Using conventional complex I assays in those conditions, the full enzyme
activity could not be regained and might be underestimated if the reac-
tion time is short. Special care should be taken when microplate reader
spectrophotometers with preprogrammed protocols with restricted
assay time are used since the phenomenon of the re-activation can be
easily overlooked.
2.2. Fatty acid and divalent cation effects
The conversion from theD- to the A-form of complex Iwas shown to
be inhibited by either an increase in pH or by the presence of divalent
cations (Fig. 1A, DSH) [11,22]. However, the NADH oxidation catalysed
by the A-form is almost insensitive to the presence of Ca2+ or Mg2+.
Divalent cations possibly neutralise negative lipid charges at the
membrane surface and therefore affect the process of conformational
changes during re-activation. The inhibitory effect of divalent cations
on the activation was found in the following order: Ni2+ N Co2+ N
Mn2+ N Ca2+≈Mg2+ N Ba2+. It should be stressed, that nickel or cobalt
ions are hypoxia-mimetics and widely used to induce HIF-1α
stabilisation in studies of the cellular oxygen sensing mechanism [38].
It cannot be excluded that the effect of cobalt on the A/D equilibrium
can partially contribute to the cellular hypoxic response during experi-
mentally observed HIF-1α stabilisation in various cell lines.
Free fatty acids not only affect the NADH oxidase and NADH:Q
oxidoreductase activities of complex I [39–41] but also inﬂuence the
dynamics of the A/D transition [42,43]. Palmitatewas shown to dramat-
ically increase the rate of spontaneous de-activation resulting in a
partially irreversible inactivation of complex I at 37 °C along with a de-
creased rate of the D to A conversion [42]. The inhibitory effect of palmi-
tate on the D→A transition is strongly cooperative indicating that the
acting species might be a fatty acid dimer [42].
Recently the effect of Ca2+ on the D→A transition was re-evaluated
usingpig brain SMP [43]. The inhibition of the turnover dependentD→A
transition was found to be due to the combined action of free fatty acids
and divalent cations. Thus Ca2+ drastically potentiates the effect of free
fatty acids possibly due to the formation of an ion-pair that would
increase fatty acid concentration in themembrane, aggravating its effect
on complex I [43].
2.3. The A/D transition among different species
The proton-translocating NADH:ubiquinone oxidoreductase is
found in many different organisms from bacteria to mammals. These
enzymes share basic catalytic properties including similar turnover
number and apparent afﬁnity constant for substrates and inhibitors
[3,6,20,44,45]. As mentioned in the Introduction, the ability to switch
from the A to the D state was originally observed in bovine heart mito-
chondria [7,46] (see [6] for historical review). Complex I is present in
various organisms and its subunit composition may vary from 14 to
44,with the 14 subunit homologue in bacteria representing the smallest
functional catalytic unit. Table 1 summarises the data available for com-
plex I from various sources, but mainly emphasises the lack of informa-
tion regarding the A/D transition in different organisms. Until now, the
only organisms in which an A/D transition has been observed are verte-
brates and fungi. The existence of the A/D transition was never tested
for the plant enzyme. Complex I from the non-vertebrate organisms
tested does not display an A/D transition although the enzyme possibly
contains numerous accessory subunits as expected for eukaryotes.
Moreover, bacterial complex I exists only in the SH-reagent insensitive
form. Therefore it is likely to correspond to the A-state despite the
presence of a few additional subunits as recently demonstrated for
Paracoccus denitriﬁcans [47] and Thermus thermophilus [48]. It is thus
possible that the presence of certain accessory subunit(s) correlates
with the A/D transition ability of the enzyme. Systematic comparison
of the subunit composition between species could reveal key structural
difference(s) that correlate with the ability of complex I to undergo de-
activation/activation. Among the vertebrate organisms displaying the
A/D transition, notable differences in the apparent activation energy de-
termined using single transition state Arrhenius equation have been ob-
served. Cold-blooded animals and fungi display an A/D transition with
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relatively low apparent activation energy, whereaswarm-blooded ones
are characterised by high apparent activation energy (Table 1).
2.4. Possible mechanism of A/D transition and subunits involved
The electron transfer from NADH to ubiquinone catalysed by com-
plex I is coupled to the translocation of four protons across the mem-
brane as measured experimentally [49,50] and recently supported by
structural studies [51]. A conformation-driven coupling mechanism
was proposed for complex I many years ago [52–55] and recently con-
ﬁrmedby Sazanov's group for the prokaryotic enzyme [51,56]. However
the precise mechanism of energy transduction requires further elucida-
tion. Extensive studies using cross-linking [57–61] or limited proteolysis
[52,62] have been carried out on both bacterial and mammalian com-
plex I. Even though the bacterial complex I does not display the A/D
transition, the analysis of cross-linking products found in the
presence/absence of substrates gives interesting information on the
part(s) of the enzyme that display a degree of ﬂexibility. This region
could also be involved in the A/D transition of the enzyme from higher
eukaryotes since activation (A→D transition) occurs as a result of a
single slow catalytic turnover.
In bovine and bacterial complex I (Escherichia coli and
Thermus thermophilus), in the presence of NAD(P)H, the quantity of
cross-linked products between the hydrophilic subunits was signiﬁcantly
reduced and susceptibility to tryptic degradation was increased [59–61].
These observations suggested a change in the conformation of complex
I upon reduction. This hypothesis was also supported by a single particle
analysis on complex I from E. coli in the presence of NADH or NAD+ [63].
In the E. coli enzyme, the subunit NuoB (PSST in the bovine complex I)
was shown to be themostmobile,moving away fromNuoI (TYKY) in the
presence of NAD(P)H. The NuoB subunit moves closer to other subunits,
potentially NuoG (75 kDa) and hydrophobic subunits such as NuoA
(ND3) or NuoH (ND1) [61]. NuoB (PSST) is known to coordinate the ter-
minal FeS cluster N2 [64,65] and is located at the interface between the
membrane and soluble domains of the enzyme, where the quinone
binding pocket is found. Kinetic analysis suggested that NADH binding
at the hydrophilic part and reduction of the enzyme redox centres led
to a change in the conformation of the quinone binding site upon reduc-
tion [66].
Taken together, these studies clearly showed a rearrangement of the
subunits around the quinone binding pocket after the binding of sub-
strate and inhibitors in the bacterial andmammalian enzyme. However,
the changes in the enzyme structure are probably relatively small,
explaining results found with zero-length cross-linkers. Indeed, the
use of cross-linker reagents with a spacer arm longer than 10 Å is un-
likely to unveil intramolecular differences [61].
The ﬁrst observation of a possible structural difference between the
A- and D-forms of mitochondrial complex I was found by Vinogradov's
group [67]. Using N-ethylmaleimide and its ﬂuorescent derivative, they
were able to show that a subunit of around 15 kDawasmodiﬁed by the
SH-reagent only in the D-form of the enzyme. The residue differentially
labelled in the D-form of complex I only was further identiﬁed by mass
spectrometry as the Cys-39 of the ND3 subunit [68]. The Cys-39 is locat-
ed in thematrix hydrophilic loop connecting the second and third trans-
membrane helices [51,68,69]. This region is an important mutation hot
spot for complex I deﬁciencies. Mutations in this region of ND3 lead to
various mitochondrial encephalopathies indicating the importance of
this loop for complex I function or regulation [70–73].
The ND3 subunit is known to participate in the formation of the
quinone reaction chamber, along with ND1, 49 kDa (Nqo4 in
T. thermophilus) and PSST (Nqo6) [51]. Changes in this region during
the A/D transition were recently demonstrated via two different ap-
proaches in our group. Cross-linking studies and ﬂuorescent labelling
followed by a DIGE-like analysis were implemented to gain a better un-
derstanding of the conformational differences between the A- and the
D-forms of complex I in bovine heart SMP.
To study the potential conformational changes in the A/D transition
of complex I, a 6.8 Å \SH/\NH2 heterobifunctional cleavable cross-
linker (SPDP) was used [74]. In the D-form of complex I, a cross-linked
product between the ND3 subunit and the accessory subunit 39 kDa
Table 1
Subunit composition and A/D transition of complex I from different organisms.
Species A/D transition Number of subunits MW (kDa) EA for de-activation (kJ/mol) EA for activation (kJ/mol)
Eukaryote
Vertebrate
Bos taurus (bovine) Yesa [11] 44 [138,139] 980 [138,139] 270 [11] 170 [11]
Rattus norvegicus (rat) Yesa [14,140] N.D. N.D. N.D. N.D.
Gallus gallus (chicken) Yesa [19] N.D. N.D. N.D. N.D.
Sus scrofa domesticus (pig) Yesa,b [141] N.D. N.D. N.D. N.D.
Rana catesbeiana (frog) Yesc,d [19] N.D. N.D. 151 [19] 66 [19]
Cyprinus caprio (carp) Yesc,d [19] N.D. N.D. 204 [19] 67 [19]
Non-vertebrate
Lumbricus terrestris (earthworm) No [19] N.D. N.D. – –
Acheta domesticus (cricket) No [19] N.D. N.D. – –
Homarus americanus (lobster) No [19] N.D. N.D. – –
Fungi
Yarrowia lipolytica Yes [19] ≥40 [142] ≥946.5 [142] ≪270 [19] N.D.
Neurospora crassa Yes [143] 39 [144] N700 [144] ≪270 [19] N.D.
Plant
Arabidopsis thaliana N.D. ~30 [145] ~1000 [146] N.D. N.D.
Algae
Chlamydomonas reinhardtii N.D. 42 [147] ~970 [147] N.D. N.D.
Prokaryote
Bacteria
Escherichia coli No [19] 14 [148] ~550 [148] – –
Paracoccus denitriﬁcans No [149] 17 [47,150] ~530 [47,150] – –
Rhodobacter capsulatus Noe 14 [151] ~550 [151] – –
Thermus thermophilus No [19] 16 [48,51] ~536 [48,51] – –
N.D.: not determined.
a Heart.
b Brain.
c Skeletal muscle.
d Liver.
e A. Galkin unpublished data.
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(NDUFA9) was observed [74]. This cross-linked product was absent
when complex I was in the A-form (i.e. pretreated with NADH). Cross-
linkers with the same reactivity but a longer arm (9.4 Å or 15.7 Å) failed
to produce clear cross-linked products, despite inhibiting the re-
activation of the D-form of the enzyme (A. Birch, M. Ciano unpublished
results). These data suggested that the 39 kDa subunit is located near
ND3, close to the quinone binding site.
Using ﬂuorescent lysine speciﬁc reagents and a DIGE-like approach,
we recently demonstrated the differential exposure of three different
subunits depending on the conformation of complex I in SMP [75].
The A- and D-forms of complex I were labelled either with cyanine ﬂuo-
rescent Cy3- or Cy5-NHS esters before separation of complex I subunits
by BN/double SDS-PAGE. As expected, the ND3 subunit was found to be
more exposed in the D-form, which corroborated the earlier observa-
tion [68]. Two additional polypeptides were found more labelled in
the D-form, namely the ND1 and the 39 kDa subunits. Together with
our cross-linking studies, these results allowed us to conclude that the
proximity of the ND3 and 39 kDa subunits in the D-form was not only
due to the changed position of the hydrophilic loop of ND3, but also to
a concerted rearrangement of these two subunits.
For the ﬁrst time, ND1 was found associated to structural rearrange-
ments uponde-activation of the enzyme. These three subunits are located
at the junctionbetween the hydrophilic andmembrane armsof complex I
and ND1 and ND3 are directly involved in the formation of the quinone
binding pocket [51]. The small number of subunits founddifferentially ex-
posed suggests rather discrete conformational changes located at the re-
gion of the quinone chamber. Interestingly, these results conﬁrm the
relative ﬂexibility of complex I in that region, as observed on the bacterial
enzyme in the presence or absence of NAD(P)H [61].
The junction region (Q-module) between the proton pumping
(P-module) and hydrophilic module that operates the electron transfer
from NADH to the terminal N2 FeS cluster (N-module) probably
displays a high degree of ﬂexibility [1]. The ability of this part of the en-
zyme to undergo conformational rearrangements would then not only
be crucial for energy transduction, as previously suggested [64–66],
but also for the process of conformational changes during the A/D tran-
sition. Therefore, de-activation of complex I would lead to the blockade
of terminal electron transfer from N2 to ubiquinone due to a structural
rearrangement of two crucial membrane subunits, ND1 and ND3. This
may occur due to the change in position of the membrane helices of
bothND3 andND1, preventing the entrance of the ubiquinonemolecule
through the narrow path from the membrane [76,77]. Equally the elec-
tron transfer blockade may be due to the alteration in the tight sealing
of the quinone binding chamber close to N2 after the movement of
the ND3 hydrophilic loop and ND1. The precise mechanism of complex
I deactivation remains to be answered.
Rotenone is a quinone-like speciﬁc inhibitor of complex I. SMP
containing either the A- or the D-form of the enzyme were subjected
to incubation with rotenone, the inhibitor was washed off and the con-
tent of both forms was determined. This resulted in a partial protection
of the A-form against de-activation but also converted the D-form to an
A-form-like conformation [78]. It has been suggested that rotenone
could act as a clamp maintaining the enzyme in the A-conformation or
inducing conformational changes in the D-form similar to the catalytic
transitory state so that the enzyme–inhibitor complex reactivates with-
out a turnover [78]. Rotenone also prevents the formation of cross-
linked products between hydrophilic subunits, suggesting that this
inhibitor could ‘lock’ complex I in a state similar to the conformation
of the reduced enzyme [57].
It would then be of strong interest to perform cross-linking studies
in both hydrophilic and hydrophobic parts of the mammalian complex
I depending on the conformation of complex I. It is tempting to specu-
late that the structural rearrangement leading to the A-state might be
similar to the one observed on the bacterial enzyme in the presence of
NADH [61]. These conformational changes could lead to a signiﬁcant
modiﬁcation of the shape of the quinone binding pocket, resulting in a
binding and/or stabilising effect. Therefore, the A/D transition of the
mammalian enzyme could have been acquired as an evolutionary pro-
cess, along with the appearance of some of the accessory subunits. As
suggested previously [79,80], accessory subunits surrounding the core
of the enzyme may serve as a protective layer preventing access of
molecular oxygen to the electron-transfer pathway of complex I. If dam-
aged, these subunits would then simply be replaced overcoming the en-
ergy required for re-synthesis and re-assembly of the entire enzyme
[80].
2.5. The A/D transition and supercomplexes
As demonstrated by extensive studies in Schagger's laboratory
[81,82] and as observed by electron microscopy [83–86], complexes of
the mitochondrial respiratory chain can be organised together into
supercomplexes with various stoichiometry. These complexes are re-
ferred to as respirasomes when they contain complexes I, III and IV as
they retain the ability to transfer electrons from NADH to oxygen after
isolationwith native electrophoresis [87–89]. It has also been suggested
that this association could facilitate electron transport through the re-
spiratory chain and prevent ROS formation [89].
The estimated apparent energy of the spontaneous A→D transition
for bovine heart mitochondrial complex I is 270 kJ/mol [11]. This
would suggest rather signiﬁcant changes in the enzyme conformation
in the membrane upon de-activation. This change could potentially
alter the supramolecular organisation of supercomplexes, if present
in situ. The 3D reconstruction of the bovine heart mitochondrial S1
supercomplex (I1 + III2 + IV1) shows that the complex III dimer sits
in the arc of the bent membrane part of complex I so that the ubiqui-
none binding sites of both complexes face each other [84]. The hydro-
philic loop of ND3 containing Cys-39 is located exactly in this area.
Therefore, if the D-form is associated with other respiratory complexes
this residue could be enclosed and inaccessible to modiﬁcation by natu-
ral effectors such as ROS [24] or nitrosothiols [90]. However, using bo-
vine SMP containing the A- or the D-form of complex I we did not ﬁnd
any difference either in supercomplex proﬁles on BN and hrCN-PAGE
or any effect on supercomplex formation and on the degree of exposure
of the Cys-39 of ND3 subunit in the D-form [75]. These results were fur-
ther indirectly conﬁrmedwith the use of cross-linkers (EEDQand EMCS,
respectively zero-length and 9.4 Å cross-linkers). The A- or the D-form
of complex I in SMP were always found cross-linked to complex IV.
These results suggest a close association of complexes I and IV indepen-
dently of complex I conformation (Amanda Birch, unpublished data).
3. Physiological role of the A/D transition
The physiological role of the A/D transition is still under discussion.
As shown previously, in tissues ex vivo [23,24], a signiﬁcant fraction of
complex I (5–15%) was found to be in the D-form at physiological oxy-
gen concentrations. As suggested previously, this indicates that part of
the energy released during steady-state NADH oxidation in situ is
used to maintain the catalytically competent A-form of the enzyme
[6]. Maintenance of a fraction of complex I in the D-form would allow
fast responses to changes in conditions such as reductive stress, in-
creased ATP demand and changes in oxygen availability by analogy
with the well known excess capacity phenomenon of the cytochrome
c oxidase [91–93]. Therefore, the A/D transition could be considered as
a mechanism for the ﬁne tuning of enzyme activity [10,19,24,25]. In
non-physiological conditions, i.e. ischemia/reperfusion, this ﬁne tuning
would protect not only complex I but also the whole respiratory chain
from oxidative damage following reperfusion.
3.1. The A/D balance at limited oxygen concentration
In conditions of limited oxygen concentration (i.e. ischaemia, chemical
or metabolic hypoxia [30,32]) mitochondrial redox components that are
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usually oxidised undergo complete reduction due to the slowing of the
cytochrome c oxidase. Complex I turnover becomes restricted by the
lack of electron acceptor ubiquinone. Accumulation of reduced quinone
then not only decreases the availability of substrate for the enzyme, but
also inhibits the physiological oxidoreductase activity of the enzyme
[94,95]. In such situations, the steady-state equilibrium in the A↔D reac-
tion is shifted to the right and complex I readily converted into theD-form
in minutes [23,24] (Fig. 1B, A→D transition).
In the Langendorff rat heart and mouse infarction models, oxygen
deprivation is shown to initiate progressive accumulation of the D-
form enzyme [23,24]. The rate of complex I de-activation after cardiac
arrest is much faster in brain compared to heart and may be due to
the different lipid composition of the inner mitochondrial membrane.
This might also explain the greater vulnerability of brain function to ox-
ygen deprivation [69].
A potential Na+/H+ antiporter activity was demonstrated for the D-
form of the bovine enzyme on proteoliposome-reconstituted complex I
and SMP [13]. It was suggested that the Na+/H+ exchange catalysed by
the D-form accumulated during the ischaemic period can contribute to
theprotection ofmitochondrial ion balance [13]. The potential antiporter
activity of the enzyme could be important for the maintenance of the
ion-balance in mitochondria during ischaemia, contributing to the regu-
lation of Na+ concentration in the cytosol [96].
3.2. The A/D transition during reoxygenation
Cardiac reperfusion following ischemia/anoxia results in the return
of complex I A/D equilibrium to its initial level (A/D ratio ≈ 9–7)
indicating that reintroduction of oxygen causes re-activation of the D-
form of the enzyme [23,24]. Therefore, the A/D transition in cardiac
tissue takes place in situ during ischaemia and this reversible process
would play a role in tissue response to oxygen deprivation (Fig. 1B,
A↔D).
As shown previously, chemical or pharmacological inhibition of
complex I during ischaemic incubation would protect mitochondria
from damage after reperfusion [90,97–101]. The presence of pyridaben,
an inhibitor of complex I, decreased lesion size in brain and reduced ox-
idative damage during hypoxia/ischaemia in neonatal mice [102]. The
presence of another complex I inhibitor, amytal, in the ischaemia/reper-
fusion (I/R) model decreased the amplitude of the free radical's EPR sig-
nal and lessened lipid peroxidation [103].
Following ischemia/anoxia, reoxygenation may initiate abnormal
bursts of NAD(P)H oxidation, ROS generation and the formation of
other reactivemetabolites capable of damagingmitochondrial constitu-
ents including complex I. The de-activation of complex I could then be a
physiological mechanism to maintain a low enzymatic activity when
oxygen concentration rises. The presence of most of complex I in the
D-state during reintroduction of oxygen to the tissue would have two
important consequences. Firstly, the slow activation of complex I during
the early phase of reoxygenation would reduce the burst of respiration
downstreamof the enzyme. Secondly, it would delay rapid formation of
potentially ROS-promoting tightly bound ubisemiquinones in complex I
[104–107] until the oxygen concentration decreases to the normoxic
steady-state level due to the activity of the cytochrome c oxidase. There-
fore, the lag-phase in complex I activity, although probably very short in
situ, would decrease the generation of ROS by the mitochondrial respi-
ratory chain and lessen the oxidative damage. It is possible that the re-
versible de-activation of complex I in the absence of oxygen may
function as a protective valve for complex I electron transfer pathway
upon tissue reoxygenation.
Another important consideration is the effect of de-activation on
reverse electron transfer. In the presence of membrane potential,
ubiquinol is able to reduce redox-centres of complex I such as all iron
sulphur clusters and ﬂavin, so that NAD+ can be reduced to NADH
[108,109]. In vitro, the reverse electron transfer is accompanied by
increased H2O2 production which is prevented by complex I inhibitors
[102,110–113]. The reduced ﬂavin of complex I is likely to be the main
source of superoxide, which is sequentially converted to H2O2
[114,115]. The D-form of the enzyme is unable to catalyse the reverse
transfer of electrons and therefore de-activation could act as a safety
valve preventing reduction of the enzyme from downstream [11].
Since in post-hypoxic conditions the entire pool of NAD(P)+ is reduced
it is unlikely that the reverse electron transfer occurs directly from
ubiquinol to the nucleotide. However, during reoxygenation, de-
activation can temporarily prevent reduction of FMN in a fraction of
the enzyme. Since respiratory chain complexes are distributed hetero-
geneously in the inner mitochondrial membrane along the cristae and
therefore can be exposed to different redox conditions (NAD(P)H/
NAD(P)+ ratio) and/or potential [116].
A critical consequence of I/R process is oxidative stress and therefore
special endogenous mechanisms should have evolved in order to ame-
liorate the damage. This damage is unlikely to be directly due to a de-
crease in the respiratory chain activity and ATP production per se, but
due to oxidative stress following reintroduction of oxygen in tissues in
the post-ischaemic overreduced state [5]. The ischaemic de-activation
of complex I might initially act as an intrinsic protective mechanism
against overproduction of ROS and provide a safeway to recover cellular
bioenergetic function to the normal state after reoxygenation.
3.3. Covalent modiﬁcations
Covalent modiﬁcation of thiol groups via reversible gluta-
thionylation, oxidation, nitrosation [117] or the formation of Michael
adducts [118] are important factors in the regulation of enzyme activity
and cellular signalling. Exposure of Cys-39 of the ND3 subunit upon
deactivation is one of the main conformational changes identiﬁed in
complex I to date. It is thought that this could be important in several
pathological scenarios [18,67,68,90].
Following the discovery that the glutathionylation of some complex
I subunits increased superoxide production by the enzyme [119] it was
tempting to speculate that the modiﬁcation of the D-form of complex I
by the GSH/GSSG couple could regulate the enzyme's activity. However,
the D-form of the enzyme was found to be insensitive to reduced or
oxidised glutathione in vitro [25,26]. Modiﬁcation of cysteine thiols in
situ, however, depends on particular conditions including: redox
environment, GSH/GSSG ratio, hydrophobicity surrounding the target
thiol, pH, ion composition, and the activity of enzymes mediating
the glutathionylation reaction: glutathione-S-transferases and the
glutaredoxin system [117,120,121].
Recently, complex I conformation-speciﬁc thiol modiﬁcations were
identiﬁed in mitochondrial membranes isolated from normoxic and
ischaemic mouse heart [24]. Exogenous H2O2 and superoxide were
found to inhibit only the D-form of complex I [24] whilst activation of
the enzyme completely abolished the ROS-mediated inhibition. Cys-39
was found to be modiﬁed in complex I during treatment with H2O2.
Once Cys-39 of the ND3 subunit is modiﬁed, complex I is thought to
be unable to undergo the D→A conversion and catalyse the physiolog-
ical NADH:ubiquinone reaction. Thus, Cys-39 may be an early mito-
chondrial target for oxidative/nitrosative stress during I/R.
Inhibition of complex I-mediated respiration was demonstrated in
cells after they were incubated with activated macrophages [122]. This
inhibition of complex I activity was found to be due to nitric oxide
(NO) [123]. Prolonged exposure to a high concentration of NO was
found to result in persistent inhibition of complex I in cells [124–126],
which was later conﬁrmed by other groups [127–131] and attributed
to nitrosation of critical thiol(s). Interestingly both the A- and D-forms
of complex I were found insensitive to direct treatment with NO in bo-
vine SMP. However, the re-activation of the D-form was inhibited by
nitrosothiols and peroxynitrite whilst the A-form was insensitive to
such treatment [25].
This was recapitulated in HEK cells producing endogenous NO [18].
Due to the inhibitory action on the cytochrome c oxidase [92,132,133],
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NO induced the de-activation of complex I in hypoxia leading to the
exposure of Cys-39 of the ND3 subunit. This thiol group is then suscep-
tible to covalent modiﬁcation by NO-metabolites. It is then expected
that modiﬁcation of this SH-group would result in inhibition of cellular
respiration. Indeed, this has been observed in HEK293-tet-iNOS cells
transfected with NO-synthase [134] and by measuring the autoﬂuores-
cence of matrix nucleotides in intact cells with confocal microscopy
[18]. This site of complex I nitrosation was identiﬁed in Murphy's
laboratory using the mitochondria-targeted S-nitrosothiol ‘MitoSNO’
[90]. MitoSNOwas found to nitrosate Cys-39 of the ND3 subunit and in-
hibit complex I after but not before ischaemia in an intact heartmodel of
cardiac I/R [90]. S-nitrosation of Cys-39 of the ND3 subunit in hypoxic
conditionswas also found to slow reactivation ofmitochondrial respira-
tion during reperfusion. This decreased reactivation rate of the enzyme
was found to be concomitant with a decrease in ROS production,
oxidative damage and tissue necrosis [90]. Exposure of Cys 39 in the
D-form of the enzyme under ischaemic conditions may act as the switch
preventing excess ROS production by the enzyme during reperfusion.
Therefore, slowing the rapid reactivation of complex I by modiﬁcation
of Cys-39 of ND3 may represent a novel therapeutic strategy that could
be important in various pathological and physiological scenarios such
as I/R, chronic inﬂammation, neurodegeneration or mitochondrially
inherited diseases.
The kinetics of the A/D transition can be signiﬁcantly affected in
different conditions but the degree of modiﬁcation of the D-form by
ROS or NO metabolites in situ is not clear at present. S-nitrosation of
the ND3 subunit is probably reversible via reduction by glutathione
and thioredoxin systems and may be protective (Fig. 1B, DSNO) [90]. Ni-
tration or oxidation of thiol groups (Fig. 1B, DS⁎), however, is irreversible
at the timescale of I/R. Prolonged exposure of the D-form of the enzyme
to low steady-state levels of endogenous SH-reactive molecules such as
S-nitrosoglutathione, peroxynitrite and ROS would lead to modiﬁcation
of a certain fraction of the enzyme. Depending on the nature of the
covalentmodiﬁcation, the fraction ofmodiﬁed enzymewould gradually
increase subject to the presence of the effector and activity of the thiol-
regenerating system. Complex I has a high degree of ﬂux control over
oxidative phosphorylation [135–137] and therefore arresting the re-
activation of even a small fraction of the enzymemay have a signiﬁcant
effect on the matrix NAD+/NADH ratio and also the membrane poten-
tial and ATP production. Depending on the magnitude and time-frame
of the process, the degree of oxidative damage and the course of recov-
ery in ischaemic tissues after reperfusion could be signiﬁcantly affected.
4. Conclusion
The transition of mitochondrial complex I from the A- to the D-state
is a unique feature of some eukaryotic enzymes, including mammals.
Themechanism of the A/D transition of the enzyme is far frombeing un-
derstood, however one of the accessory subunit, 39 kDa (NDUFA9) and
two mitochondrially encoded subunits, ND3 and ND1, all located in the
area of the quinone binding site are involved in conformational rear-
rangements. It is unlikely that the A/D transition is induced by changes
in the respiratory chain supercomplex assembly. The driving force of the
A/D transition, the mechanism of the electron transfer blockage in the
D-form and other potential accessory subunits involved remain to be
clariﬁed.
Results fromour and other laboratories suggest that accumulation of
the D-form of complex I occurs in mitochondria-rich tissues during ox-
ygen deprivation. The rate of accumulation of the D-form of the enzyme
during ischaemia can be modulated by elevated temperature, the pres-
ence of free fatty acids and divalent cations. This would affect the redox
state of cofactors and reactive centres upstream and downstream of the
enzyme. The A/D transitionmay represent a naturalmechanism provid-
ing a fast mitochondrial response to oxygen deprivation. Deceleration
in the activity of the respiratory chain due to the slow activation of
the D-form during the initial phase of reoxygenation would prevent
mitochondrial generation of ROS, decreasing oxidative damage. Howev-
er, the cysteine-39 of theND3 subunit, exposed in theD-form, is suscep-
tible to covalent modiﬁcation by ROS and NOmetabolites. Accumulated
D-form could react with natural effectors inmitochondria or with phar-
macological agents during periods of hypoxia or reoxygenation. This
wouldmodulate theprocess of reactivation of the enzymeand therefore
determine the outcome of the I/R event.
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